Dec 20, 2019 / 02:30PM GMT
Operator
Ladies and gentlemen, welcome to the Poxel conference call. I now hand over to Jonae Barnes. Madam, please go ahead.
Jonae R. Barnes - Poxel SA - SVP of IR & Public Relations
Great. Thank you for joining us today. I'm Jonae Barnes, Senior Vice President of Investor Relations and Public Relations. With me on the call today are Thomas Kuhn, CEO; Pascale Fouqueray, EVP of Early Development and Translational Medicine; Julie Dubourg, Medical Director; and Noah Beerman, President of U.S. Operations and Executive Vice President of Business Development.
Before we begin, I would like to read our forward-looking statements. Some of the statements contained in this presentation constitute forward-looking statements, which are statements that are not historical facts. These statements are based on the company's current strategy, plans, objectives, assumptions, estimates and projections. Investors should, therefore, not place undue reliance on those statements. The company makes no representation, warranty or prediction that the results anticipated by such
Poxel SA - Special Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
